Publications du CNR en 2013

Agrawal, A., Roué, M., Spitzfaden, C., Petrella, S., Aubry, A., Hann, M., Bax, B. and Mayer, C. (2013). Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion. Biochemical Journal 456, 263–273, http://doi.org/10.1042/BJ20130538.

Bernard, C., Brossier, F., Sougakoff, W., Veziris, N., Frechet-Jachym, M., Metivier, N., Renvoise, A., Robert, J., Jarlier, V. and On Behalf Of The Mdr-Tb Management Group Of The Nrc, C. (2013). A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. Euro Surveill 18, URL: http://www.eurosurveillance.org/images/dynamic/EE/V18N33/art20555.pdf.

Bernard, C., Wichlacz, C., Rigoreau, M., Sorhouet, S., Dagiral, R., Jarlier, V. and Veziris, N. (2013). Evaluation of the Fluo-RAL Module for Detection of Tuberculous and Nontuberculous Acid-Fast Bacilli by Fluorescence Microscopy. J Clin Microbiol 51, 3469–3470, http://doi.org/10.1128/JCM.01910-13.

Bouige, A., Darmon, A., Piton, J., Roue, M., Petrella, S., Capton, E., Forterre, P., Aubry, A. and Mayer, C. (2013). Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes. Biochemical Journal 455, 285–294, http://doi.org/10.1042/BJ20130430.

Bui, T. V., Meyssonnier, V., Boelle, P. Y., Che, D., Antoine, D., Jarlier, V. and Robert, J. (2013). Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007. Epidemiol Infect 1–7, http://doi.org/10.1017/S0950268813002276.

Falzon, D., Gandhi, N., Migliori, G. B., Sotgiu, G., Cox, H. S., Holtz, T. H., Hollm-Delgado, M.-G., Keshavjee, S., DeRiemer, K., Centis, R., D’Ambrosio, L., Lange, C. G., Bauer, M. and Menzies, D. (2013). Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J 42, 156–168, http://doi.org/10.1183/09031936.00134712.

Fillion, A., Aubry, A., Brossier, F., Chauffour, A., Jarlier, V. and Veziris, N. (2013). Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis. Antimicrob Agents Chemother 57, 4496–4500, http://doi.org/10.1128/AAC.00506-13.

Fraisse, P. and Veziris, N. (2013). Tuberculose. In: La pneumologie fondée sur des Preuves, Margaud-Orange.

Gomez, C., Ponien, P., Serradji, N., Lamouri, A., Pantel, A., Capton, E., Jarlier, V., Anquetin, G. and Aubry, A. (2013). Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry 21, 948–956, http://doi.org/10.1016/j.bmc.2012.12.011.

Grammatico-Guillon, L., Lanotte, P., Bastides, F., Veziris, N., Bernard, L. and Rosset, P. (2013). Voluminous pseudotumor due to Mycobacterium malmoense. Presse Med 42, 227–230, http://doi.org/10.1016/j.lpm.2012.02.042.

Hillemann, D., Hoffner, S., Cirillo, D., Drobniewski, F., Richter, E., Rüsch-Gerdes, S., Network, the B.-N. T.-L., Pan-Net, T. and Networks, E. E.-T. (2013). First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries. PLOS ONE 8, e76765, http://doi.org/10.1371/journal.pone.0076765.

Lloret-Linares, C., Mouly, S., Hoang-Nguyen, D.-T., Evans, J., Raskine, L., Lopes, A., Cambau, E., Bergmann, J.-F. and Sellier, P. (2013). Inadequate Therapeutic Response to a Recommended Antituberculosis Fixed-Dose Combination Regimen in an Overweight Patient with Mycobacterium bovis Infection. Ann Pharmacother 47, e4–e4, http://doi.org/10.1345/aph.1R452.

Mechaï, F., Veziris, N., Aoun, O., Bille, E., Lecuit, M., Brossier, F., Viard, J. P. and Lortholary, O. (2013). In vivo selection of a multidrug-resistant Mycobacterium avium isolate in a patient with AIDS. Int J Tuberc Lung Dis 17, 141–142, http://doi.org/10.5588/ijtld.12.0778.

Migliori, G. B., Sotgiu, G., Gandhi, N. R., Falzon, D., DeRiemer, K., Centis, R., Hollm-Delgado, M.-G., Palmero, D., Pérez-Guzmán, C., Vargas, M. H., D’Ambrosio, L., Spanevello, A., Bauer, M., Chan, E. D., Schaaf, H. S., Keshavjee, S., Holtz, T. H., Menzies, D., Mdr-Tb, T. C. G. for M.-A. of I. P. D. in, Ahuja, S., Ashkin, D., Avendano, M., Banerjee, R., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Chiang, C.-Y., Cox, H., Dung, N. H., Enarson, D., Flanagan, K., Flood, J., Garcia-Garcia, L., Granich, R. M., Iseman, M. D., Jarlsberg, L. G., Kim, H. R., Koh, W. J., Lancaster, J., Lange, C., Lange, W. C. M. de, Leimane, V., Leung, C. C., Li, J., Mishustin, S. P., Mitnick, C. D., Narita, M., O’Riordan, P., Pai, M., Park, S. K., Pasvol, G., Pena, J., Ponce-de-Leon, A., Quelapio, M. I. D., Riekstina, V., Robert, J., Royce, S., Seung, K. J., Shah, L., Shim, T. S., Shin, S. S., Shiraishi, Y., Sifuentes-Osornio, J., Strand, M. J., Tabarsi, P., Tupasi, T. E., Altena, R. van, Walt, M. V. der, Werf, T. S. V. der, Viiklepp, P., Westenhouse, J., Yew, W. W. and Yim, J. J. (2013). Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J 42, 169–179, http://doi.org/10.1183/09031936.00136312.

Mougari, F., Guglielmetti, L., Lopes, A., Raskine, L. and Cambau, E. (2013). Mycobactérioses non tuberculeuses hors mycobactérioses cutanées. In: Revue Encyclopédie Médico Chirurgicale,.

Pang, S., Renvoisé, A., Perret, C., Guinier, M., Chelghoum, N., Brossier, F., Capton, E., Jarlier, V. and Sougakoff, W. (2013). Whole-Genome Sequence of Mycobacterium abscessus Clinical Strain V06705. Genome Announc 1, e00690-13, http://doi.org/10.1128/genomeA.00690-13.

Radomski, N., Roguet, A., Lucas, F. S., Veyrier, F. J., Cambau, E., Accrombessi, H., Moilleron, R., Behr, M. A. and Moulin, L. (2013). atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples. BMC Microbiology 13, 277, http://doi.org/10.1186/1471-2180-13-277.

Renvoisé, A., Brossier, F., Sougakoff, W., Jarlier, V. and Aubry, A. (2013). Broad-range PCR: Past, present, or future of bacteriology? Médecine et Maladies Infectieuses 43, 322–330, http://doi.org/10.1016/j.medmal.2013.06.003.

Robert, J., Affolabi, D., Awokou, F., Nolna, D., Manouan, B. A. P., Acho, Y. B., Gninafon, M. and Trebucq, A. (2013). Assessment of organizational measures to prevent nosocomial tuberculosis in health facilities of 4 sub-Saharan countries in 2010. Infect Control Hosp Epidemiol 34, 190–195, http://doi.org/10.1086/669085.

Veziris, N. (2013). Les nouveaux antituberculeux (2) : nouvelles molécules. Journal des Anti-infectieux, http://doi.org/10.1016/j.antinf.2013.06.001.

Veziris, N. (2013). Les nouveaux antituberculeux (1) : nouvelles utilisations de molécules existantes. Journal des Anti-infectieux 15, 95–101, http://doi.org/10.1016/j.antinf.2013.03.001.

Veziris, N., Chauffour, A., Escolano, S., Henquet, S., Matsuoka, M., Jarlier, V. and Aubry, A. (2013). Resistance of M. leprae to Quinolones: A Question of Relativity? PLoS Negl Trop Dis 7, e2559, http://doi.org/10.1371/journal.pntd.0002559.